Brandes et al. [218], in a comparative, observational study, evaluated sepsis, community-acquired pneumonia (CAP), systemic inflammatory response syndrome (SIRS), and COVID-19 patients to investigate the relationships between PGRN plasma levels between severely ill patients in comparison with healthy controls. This evidence concerns the gene GRN and COVID-19.